West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
Ticker SymbolWST
Company nameWest Pharmaceutical Services Inc
IPO dateSep 01, 2059
CEOGreen (Eric Mark)
Number of employees10600
Security typeOrdinary Share
Fiscal year-endSep 01
Address530 Herman O. West Drive
CityEXTON
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code19341
Phone16105942900
Websitehttps://www.westpharma.com/
Ticker SymbolWST
IPO dateSep 01, 2059
CEOGreen (Eric Mark)